ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119072	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 04/01/2026 at 22:05, 2 months 19 days ago

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Abivax publishes financial reports with French and U.S. regulatory agencies, including Universal Registration Document and Annual Report. Company focuses on immune response in chronic inflammatory diseases with lead drug candidate in Phase 3 trials

Abivax Ulcerative Colitis Financial Reports Immune Response Regulatory Agencies
BRIEF

published on 03/27/2026 at 18:05, 2 months 24 days ago

ABIVAX: Details on Share Capital and Voting Rights as of February 28, 2026

Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF

published on 03/27/2026 at 18:05, 2 months 24 days ago

ABIVAX : Détails sur le Capital Social et les Droits de Vote au 28 février 2026

Euronext Paris Droits De Vote Capital Social Actions Abivax
PRESS RELEASE

published on 03/27/2026 at 18:00, 2 months 24 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 28.02.26.
ABIVAX communique le nombre d'actions et de droits de vote au 28.02.26, conformément aux réglementations financières. ABIVAX est une société de biotechnologie axée sur les traitements des maladies inflammatoires

Droits De Vote Biotechnologie Actions Abivax Maladies Inflammatoires
BRIEF

published on 03/23/2026 at 21:10, 2 months 28 days ago

Abivax présente ses résultats 2025 et ses perspectives

Obefazimod Résultats Financiers 2025 Trésorerie 2027 DSMB ABTECT Nominations Cadres
BRIEF

published on 03/23/2026 at 21:10, 2 months 28 days ago

Abivax presents its 2025 results and outlook

Obefazimod Management Appointments 2025 Financial Results DSMB ABTECT Cash Flow 2027
BRIEF

published on 03/23/2026 at 21:10, 2 months 28 days ago

Abivax publie ses résultats financiers pour l'exercice 2025 et fait le point sur ses activités.

Résultats Financiers Biotechnologie Obefazimod Essais Cliniques Nominations De Dirigeants
BRIEF

published on 03/23/2026 at 21:10, 2 months 28 days ago

Abivax Reports Full Year 2025 Financial Results and Business Updates

Financial Results Biotechnology Obefazimod Clinical Trials Leadership Appointments
PRESS RELEASE

published on 03/23/2026 at 21:05, 2 months 28 days ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités. Nomme de nouveaux cadres dirigeants et annonce des données clés pour l'avenir

Résultats Financiers Abivax DSMB Cadres Dirigeants Avenir
PRESS RELEASE

published on 03/23/2026 at 21:05, 2 months 28 days ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Abivax reports full year 2025 financial results and key business updates, including safety updates, pivotal Phase 3 trial progress, senior leadership appointments, and upcoming milestones. Strong cash position and strategic plans highlighted

Financial Results Abivax Phase 3 Trial Leadership Appointments Business Updates

Accesswire

Published on 06/20/2026 at 01:00, 1 day 9 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 10 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 6 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 9 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 9 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 13 hours 8 minutes ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 4 hours ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 14 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 14 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 15 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

Les Echos

Published on 06/19/2026 at 19:33, 1 day 15 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 15 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 15 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 15 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 15 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE